mnexspike moderna - Search News

News

Moderna Stock Climbs

Drug Store News · 6h

Moderna obtains FDA OK for mNEXSPIKE COVID-19 vaccine

The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that puts them at high risk.

USA TODAY · 5d

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283),

ConsumerAffairs3d

Moderna wins FDA approval for its new COVID-19 vaccine

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

1don MSN

RFK Jr. says Moderna agreed to another clinical trial to support new COVID shot

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results